There have been a couple of mentions recently of antiangiogenesis drugs.
After the big splash a couple of years ago, things have been quiet during the
hard work of clinical trials. Any word from the front on how those trials
are going?
Greg Burch <GBurch1@aol.com>----<gburch@lockeliddell.com>
Attorney ::: Vice President, Extropy Institute ::: Wilderness Guide
http://users.aol.com/gburch1 -or- http://members.aol.com/gburch1
ICQ # 61112550
"We never stop investigating. We are never satisfied that we know
enough to get by. Every question we answer leads on to another
question. This has become the greatest survival trick of our species."
-- Desmond Morris
This archive was generated by hypermail 2b29 : Thu Jul 27 2000 - 14:06:23 MDT